PMS31 COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN BIOLOGIC-NAIVE PATIENTS FROM THE PORTUGUESE PERSPECTIVE
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.1575
https://www.valueinhealthjournal.com/article/S1098-3015(19)33953-1/fulltext
Section Title :
Section Order :
11367
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33953-1&doi=10.1016/j.jval.2019.09.1575